How many modes of action should an antibiotic have?

被引:90
作者
Broetz-Oesterhelt, Heike [1 ]
Brunner, Nina A. [1 ]
机构
[1] AiCuris GmbH & Co KG, D-42117 Wuppertal, Germany
关键词
D O I
10.1016/j.coph.2008.06.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
All antibiotics that have been successfully employed for decades as monotherapeutics in the treatment of bacterial infections rely on mechanisms of bacterial growth inhibition which are by far more complex than inhibition of a single enzyme. Such successful antibiotics have in common that they address several targets in parallel and/or that their targets are encoded by multiple genes. Such multiplicity of targets and of target genes has the advantage that the emergence of spontaneous target-related resistance is a comparatively slow process. Recently registered antibiotics and novel antibiotics in development are discussed in the light of this promising concept of antibacterial polypharmacology.
引用
收藏
页码:564 / 573
页数:10
相关论文
共 50 条
  • [1] Molecular mechanisms of antibacterial multidrug resistance
    Alekshun, Michael N.
    Levy, Stuart B.
    [J]. CELL, 2007, 128 (06) : 1037 - 1050
  • [2] Mechanism of action of oritavancin and related glycopeptide antibiotics
    Allen, NE
    Nicas, TI
    [J]. FEMS MICROBIOLOGY REVIEWS, 2003, 26 (05) : 511 - 532
  • [3] Structural insight into the antibiotic action of telithromycin against resistant mutants
    Berisio, R
    Harms, J
    Schluenzen, F
    Zarivach, R
    Hansen, HAS
    Fucini, P
    Yonath, A
    [J]. JOURNAL OF BACTERIOLOGY, 2003, 185 (14) : 4276 - 4279
  • [4] Ketolides lack inducibility properties of MLSB resistance phenotype
    Bonnefoy, A
    Girard, AM
    Agouridas, C
    Chantot, JF
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 85 - 90
  • [5] Dual action-based approaches to antibacterial agents
    Bremner, John B.
    Ambrus, Joseph I.
    Samosorn, Siritron
    [J]. CURRENT MEDICINAL CHEMISTRY, 2007, 14 (13) : 1459 - 1477
  • [6] Bryskier A, 1997, Expert Opin Investig Drugs, V6, P1479, DOI 10.1517/13543784.6.10.1479
  • [7] Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound
    Butler, Michelle M.
    LaMarr, William A.
    Foster, Kimberly A.
    Barnes, Marjorie H.
    Skow, Donna J.
    Lyden, Patrick T.
    Kustigian, Lauren M.
    Zhi, Chengxin
    Brown, Neal C.
    Wright, George E.
    Bowlin, Terry L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (01) : 119 - 127
  • [8] Chopra I, 2007, CURR OPIN INVEST DR, V8, P600
  • [9] Ribosomal protection proteins and their mechanism of tetracycline resistance
    Connell, SR
    Tracz, DM
    Nierhaus, KH
    Taylor, DE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) : 3675 - 3681
  • [10] Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae
    Davies, Todd A.
    Page, Malcolm G. P.
    Shang, Wenchi
    Andrew, Ted
    Kania, Malgosia
    Bush, Karen
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) : 2621 - 2624